The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Rainer Knoll, Elisa T. Helbig, Kilian Dahm, Olufemi Bolaji, Frederik Hamm, Oliver Dietrich, Martina van Uelft, Sophie Müller, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Lev Petrov, Benjamin Krämer, Michael Kraut, Paula Stubbemann, Charlotte Thibeault, Sophia Brumhard, Heidi Theis, Gudrun Hack, Elena De Domenico, Jacob Nattermann, Matthias Becker, Marc D. Beyer, David Hillus, Philipp Georg, Constantin Loers, Janina Tiedemann, Pinkus Tober-Lau, Lena Lippert, Belén Millet Pascual-Leone, Frank Tacke, Gernot Rohde, Norbert Suttorp, Martin Witzenrath, Antoine-Emmanuel Saliba, Thomas Ulas, Julia K. Polansky, Birgit Sawitzki, Leif E. Sander, Joachim L. Schultze, Anna C. Aschenbrenner, Florian Kurth

Journal title: Cell

Journal number: 187

Journal publisher: Elsevier BV

Published year: 2024

DOI identifier: 10.1016/J.CELL.2024.06.014

ISSN: 0092-8674